Partners

This book has been made possible through the support of Odgers Berndtson, a world leader since 1965 in assessing, selecting, recruiting, and developing talented individuals to lead organizations. The firm’s strength lies in the partnerships it develops to address the strategic and operational needs of its clients. Built on a culture of collaboration, respect, and humility, the firm’s 1200 employees provide focused expertise in over fifty business sectors. With 62 offices in 29 countries, Odgers Berndtson operates at the top of executive search and leadership consulting, serving Board Chairmen, Boards of Directors, and Chief Executive Officers.

In the early spring of 1990, Dr. Roscoe Brady (right) and Dr. Norman Barton (left) look over the abdominal MRI scans of twelve patients from the registration clinical trial being conducted at NIH and sponsored by Genzyme. The successful trial led to Ceredase’s approval by the FDA on April 5, 1991 for the treatment of Gaucher disease. (Courtesy, Dr. Norman Barton.)

Drs. Brady and Barton reviewing abdominal MRI scan_Folder2_Fig12A

Genzyme was named to the Fortune 500 in May 2010, an achievement of which Termeer was justifiably proud and which he memorialized by framing the magazine’s cover page, hanging it in his office at the Yellow House. (Courtesy, the Henri A. Termeer Family; photo by John Hawkins.)

Scroll over photographs to read captions.